Podcast Center
Video Center
Webcasts
Resource Center
Events
September 21, 2015 at 08:53 AM
(Bloomberg) — Biotechnology stocks fell Monday after Democratic presidential candidate Hillary Clinton tweeted Monday that she would release a plan to combat the high cost of prescription drugs.
The Nasdaq Biotechnology Index fell 3.4 percent to 3,606.07 at 12:16 p.m. in New York, the biggest intraday drop since since Aug. 24, with most of the decline coming after Clinton’s comment on Twitter.
“Price gouging like this in the specialty drug market is outrageous,” Clinton tweeted at 10:56 a.m. “Tomorrow I’ll lay out a plan to take it on.”
Clinton was responding to reports about how Turing Pharmaceuticals LLC had acquired an older antibiotic drug, Daraprim, and raised the price by more than 50-fold.
